GREGORY CHEATHAM: Open Payments
NPI 1003844754 · DECATUR, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,086 in 53 payments from 13 companies in 2025. Trend: 2023 $1,704 · 2024 $1,395 · 2025 $1,086
Food & beverage: $1,086
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $260 |
| Indivior Inc. | 5 | $160 |
| AstraZeneca Pharmaceuticals LP | 8 | $158 |
| Novo Nordisk Inc | 4 | $86 |
| Antares Pharma, Inc. | 3 | $82 |
| Amgen Inc. | 4 | $60 |
| ABBVIE INC. | 3 | $58 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $51 |
| Otsuka America Pharmaceutical, Inc. | 2 | $48 |
| PFIZER INC. | 3 | $47 |
Products named: CAPLYTA, SUBLOCADE, FARXIGA, XYOSTED, Kerendia, AIRSUPRA, REXULTI, Ozempic.
Industry payments across AL — which companies pay providers there.
